Literature DB >> 8954910

Cytokine and low-level nitric oxide prestimulation block p53 accumulation and apoptosis of RAW 264.7 macrophages.

B Brüne1, C Gölkel, A von Knethen.   

Abstract

Nitric oxide causes apoptotic cell death in RAW 264.7 macrophages. The cellular response to the NO donor S-nitrosoglutathione (GSNO) comprises an apoptotic morphology and DNA fragmentation, which largely depends on the accumulation of the tumor suppressor gene product p53. Pre-treatment of macrophages with LPS, IFN-gamma in the presence of NG-monomethyl-L-arginine (NMMA) imparts resistance to apoptotic cell death, normally elicited by exogenously-supplied GSNO. Similarly, pre-treatment with low-dose GSNO (25-200 microM) conferred resistance from a second exposure to a higher dose of GSNO (1 mM). Protection is comprehended at the level of blocked p53 accumulation. Upregulation of protective mechanisms in response to non-lethal NO concentrations or by LPS, cytokine pre-stimulation may redirect the ability of nitric oxide to upregulate p53 and to initiate macrophage apoptosis, thereby modulating cellular susceptibility towards NO-intoxication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954910     DOI: 10.1006/bbrc.1996.1816

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059.

Authors:  S Mohr; T S McCormick; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

2.  NO-Evoked macrophage apoptosis is attenuated by cAMP-induced gene expression.

Authors:  A von Knethen; F Brockhaus; I Kleiter; B Brüne
Journal:  Mol Med       Date:  1999-10       Impact factor: 6.354

3.  Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer.

Authors:  Jamboor K Vishwanatha; Ryan Swinney; Abhijit G Banerjee
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

4.  Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.

Authors:  Charlotta Ryk; Lotta Renström Koskela; Tomas Thiel; N Peter Wiklund; Gunnar Steineck; Martin C Schumacher; Petra J de Verdier
Journal:  Redox Biol       Date:  2015-08-10       Impact factor: 11.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.